Author(s)

Ignacio Vélez-Rodríguez¹, Victoria Carranza-Aranda²

¹Facultad Mexicana de Medicina, Universidad La Salle, Tlalpan, México.
²Hospital General de México, Cuauhtémoc, México.

Acute lymphoblastic leukemia (ALL) is characterized by immature and poorly differentiated B lymphocytes in large numbers in the blood. B cells are distinct from the cell types involved in their development (common lymphoid progenitor cells, pro-B cells, pre-B cells, and mature cells). The process of B cell maturation depends on precise communication within the cell: signals activate specific genes that are essential for proper development. Errors in this intricate signaling network can lead to issues with B cell function and contribute to disease. B-lineage acute lymphoid leukemias, malignancies of precursor-stage B lymphoid cells inhibit lymphoid differentiation, leading to abnormal cell proliferation and survival. The process of developing leukemia (leukemogenesis) can be triggered by an overproduction of both hematopoietic stem cells (the cells that form all blood cells) and the immature versions of white blood cells called lymphoblasts. Acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (ALL Ph) is classified as a high-risk manifestation of the disease, this chromosome is the product of the reciprocal translocation, whose product is a BCR-ABL fusion protein. It is a highly active tyrosine kinase that can transform hematopoietic cells into cytokine-independent. Hyperphosphorylation cascades inhibit the differentiating function of IKZF1 as a tumor suppressor gene which leads to an abnormal proliferation of B cells due to the presence of the Philadelphia chromosome; it inhibits the differentiating process, leukemogenesis involving immature B cells in the bloodstream can result from the uncontrolled growth and division of hematopoietic stem cells and immature lymphoblasts (the precursors to B cells).

Acute Lymphoblastic Leukemia, IKAROS, Dephosphorylation, Philadelphia Chromosome, CK2

Vélez-Rodríguez, I. and Carranza-Aranda, V. (2024) Damage Mechanism of CK2 and IKAROS in Philadelphia Like Acute Lymphoblastic Leukemia. Journal of Biosciences and Medicines, 12, 49-59. doi: 10.4236/jbm.2024.124005.